Myocardial remodeling after discrete radiofrequency injury: Effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 4 55-4, 2004, Pages

  Mukherjee, Rupak ^a,b   Parkhurst, Andrea M ^a   Mingoia, Joseph T ^a   Sweterlitsch, Sarah E ^a   Leiser, Jennifer S ^a   Escobar, G Patricia ^a   Spinale, Francis G ^a,b   Saul, J Philip ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Mouse; Myocardial remodeling; Tissue inhibitors of metalloproteinases 1

Indexed keywords

COLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPICARDIUM; GENE DELETION; HEART MUSCLE; HEART VOLUME; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RADIATION INJURY; RADIOFREQUENCY RADIATION; REGULATORY MECHANISM; THICKNESS; TIBIA SHAFT;

ANIMALS; COLLAGEN; ENZYME ACTIVATION; GENE DELETION; MATRIX METALLOPROTEINASE 1; MICE; MYOCARDIUM; ORGAN SIZE; RADIATION INJURIES, EXPERIMENTAL; RADIO WAVES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VENTRICULAR REMODELING;

EID: 1642414067     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00437.2003     Document Type: Article

References (20)

1. Blaufox AD, Felix GL, and Saul JP. Radiofrequency catheter ablation in infants < 18 mo old: when is it done and how do they fare? Short-term data from the Pediatric Ablation Registry. Circulation 104: 2803-2808, 2001.
2. Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SKS, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, and Prystowsky E. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. Circulation 99: 262-270, 1999.
3. Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, Hapke E, Hauet AM, Escobar PG, Cleutjens JP, Smits JF, Daemen MJ, Zile MR, and Spinale FG. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 284: H364-H371, 2003.
4. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, and Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62, 2000.
5. Erickson CC, Walsh EP, Triedman JK, and Saul JP. Efficacy and safety of radiofrequency ablation in infants and young children <18 months of age. Am J Cardiol 74: 944-947, 1994.
6. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, and Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29-32, 1992.
7. Kim H, Oda T, Lopez-Guisa J, Wing D, Edwards DR, Soloway PD, and Eddy AA. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 12: 736-748, 2001.
8. Li YY, Feldman AM, Sun Y, and McTiernan CF. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98: 1728-1734, 1998.
9. Li YY, McTiernan CF, and Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46: 214-224, 2000.
10. Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS, Escobar GP, Lucas DG, Yarbrough WM, Zile MR, and Spinale FG. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 107: 618-625, 2003.
11. Nath S, DiMarco JP, and Haines DE. Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol 5: 863-876, 1994.
12. Nath S, Redick JA, Whayne JG, and Haines DE. Ultrastructural observations in the myocardium beyond the region of acute coagulation necrosis following radiofrequency catheter ablation. J Cardiovasc Electrophysiol 5: 838-845, 1994.
13. Nothnick WB, Soloway PD, and Curry TE, Jr. Pattern of messenger ribonucleic acid expression of tissue inhibitors of metalloproteinases (TIMPs) during testicular maturation in male mice lacking a functional TIMP-1 gene. Biol Reprod 59: 364-370, 1998.
14. Peterson JT, Li H, Dillon L, and Bryant JW. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46: 307-315, 2000.
15. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, and Lee RT. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99: 3063-3070, 1999.
16. Roten L, Nemoto S, Simsic J, Coker ML, Rao V, Baicu S, Defreyte G, Soloway PJ, Zile MR, and Spinale FG. Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice. J Mol Cell Cardiol 32: 109-120, 2000.
17. Saul JP, Hulse JE, Papagiannis J, Van Praagh R, and Walsh EP. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation 90: 492-499, 1994.
18. Spinale FG, Gunasinghe H, Sprunger PD, Baskin JM, and Bradham WC. Extracellular degradative pathways in myocardial remodeling and progression to heart failure. J Card Fail 8: S332-S338, 2002.
19. Sutton MG and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988, 2000.
20. Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, and Armstrong PW. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 82: 1387-1401, 1990.